Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9JH3

CMF-019 with APLNR-Gi complex

This is a non-PDB format compatible entry.
Summary for 9JH3
Entry DOI10.2210/pdb9jh3/pdb
EMDB information61470
DescriptorGuanine nucleotide-binding protein G(i) subunit alpha-1, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Apelin receptor, ... (6 entities in total)
Functional Keywordscomplex, agonist, membrane protein, membrane protein-immune system complex, membrane protein/immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains5
Total formula weight154169.07
Authors
Tian, X.W.,Zhao, C.,Feng, Y.Y.,Shao, Z.H. (deposition date: 2024-09-08, release date: 2025-04-23, Last modification date: 2025-05-14)
Primary citationSun, Q.,Tian, X.,Tan, L.,Deng, Y.,Liu, S.,Xiong, Y.,Feng, Y.,Wang, Y.,Zhang, L.,Zhu, J.,Xiao, H.,Shao, Z.,Guo, Y.,Yan, W.,Li, T.,Ouyang, L.
Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy.
Proc.Natl.Acad.Sci.USA, 122:e2423432122-e2423432122, 2025
Cited by
PubMed Abstract: Heart failure with preserved ejection fraction (HFpEF) represents a significant global health burden, yet effective pharmacotherapies remain elusive. The angiotensin-like 1 receptor, also known as the apelin receptor (APLNR), is a promising target for treating HFpEF due to its role in modulating cardiovascular function. Despite the cardioprotective effects of endogenous ligand, apelin, achieving G-protein-biased agonism for therapeutic benefit poses a significant challenge. In this study, we unravel the biased signal transduction pathway mediated by a reported partial G-protein-biased APLNR agonist CMF-019 and developed a biased chemical space remodeling approach to identify exclusive G-protein-biased agonists targeting APLNR. These agonists exhibited enhanced Gi-protein-biased function and protective effects in both in vitro and in vivo. Our findings not only enhance comprehension of APLNR-biased agonism but also establish drug design strategies for modifying and reshaping biased chemical landscapes in other G-protein-coupled receptors (GPCRs).
PubMed: 40314976
DOI: 10.1073/pnas.2423432122
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.93 Å)
Structure validation

236371

PDB entries from 2025-05-21

PDB statisticsPDBj update infoContact PDBjnumon